- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Infinity Pharmaceuticals Inc+ Add to Watchlist
INFI:US10.1500 USD 0.4500 4.25%
As of 20:10:00 ET on 04/17/2014.
Company Profile for Infinity Pharmaceuticals Inc (INFI)
Infinity Pharmaceuticals, Inc. researches and develops cancer drugs. The Company uses small molecule drug technologies in the development of its products.
Infinity Pharmaceuticals Inc
Key Executives for Infinity Pharmaceuticals Inc (INFI)
|Adelene Q PerkinsChairman/President/CEO||David A RothChief Medical Officer|
|Vito J PalombellaChief Scientific Officer||Julian AdamsPresident:Research & Dev|
|Lawrence E Bloch "Larry"Exec VP/CFO/Chief Bus Officer|